Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, blood transfusion bags, and dialysis equipment.
This report aims to provide a comprehensive presentation of the global market for Anticoagulation Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulation Therapy. This report contains market size and forecasts of Anticoagulation Therapy in global, including the following market information:
Global Anticoagulation Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anticoagulation Therapy market was valued at US$ 26630 million in 2022 and is projected to reach US$ 43100 million by 2029, at a CAGR of 7.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Novel Oral Anticoagulants (NOACs) have major pharmacologic benefits over warfarin, which is a vitamin K antagonist, together with the rapid onset/offset of action, few drug interactions and predictable pharmacokinetics. Warfarin has a limited therapeutic window that can be strike by factors such as diet and enabling patients on warfarin to monitor their INR regularly. Novel oral anticoagulant (NOACs) is the top performing segment as an alternative to anticoagulant. Increasing number of patients with lifelong medical aid therapy, growing prevalence of blood vessel thromboembolism, arrhythmia, and stroke, acceptance of NOAC?s is raising revenue in the market, rising outpatient anticoagulation therapy, increasing number of pipeline products under clinical trials and rising heparin trade spurring the growth of anticoagulation therapy market. However, high cost of developing drugs and risk of malfunctions like increased bleeding is main issue with newer agents are expected to impact the target market negatively.
We surveyed the Anticoagulation Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticoagulation Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anticoagulation Therapy Market Segment Percentages, by Type, 2022 (%)
NOACs
Warfarin
Global Anticoagulation Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anticoagulation Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital Associated Clinics
Independent Clinics
Pharmacy-Based Clinics
Global Anticoagulation Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anticoagulation Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticoagulation Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anticoagulation Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CH Boehringer Sohn
Bristol-Myers Squibb
Johnson?Johnson
Pfizer
Daiichi Sankyo
Portola Pharmaceuticals
Roche
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anticoagulation Therapy, market overview.
Chapter 2: Global Anticoagulation Therapy market size in revenue.
Chapter 3: Detailed analysis of Anticoagulation Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anticoagulation Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anticoagulation Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticoagulation Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticoagulation Therapy Overall Market Size
2.1 Global Anticoagulation Therapy Market Size: 2022 VS 2029
2.2 Global Anticoagulation Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anticoagulation Therapy Players in Global Market
3.2 Top Global Anticoagulation Therapy Companies Ranked by Revenue
3.3 Global Anticoagulation Therapy Revenue by Companies
3.4 Top 3 and Top 5 Anticoagulation Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anticoagulation Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anticoagulation Therapy Players in Global Market
3.6.1 List of Global Tier 1 Anticoagulation Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Anticoagulation Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anticoagulation Therapy Market Size Markets, 2022 & 2029
4.1.2 NOACs
4.1.3 Warfarin
4.2 By Type - Global Anticoagulation Therapy Revenue & Forecasts
4.2.1 By Type - Global Anticoagulation Therapy Revenue, 2018-2023
4.2.2 By Type - Global Anticoagulation Therapy Revenue, 2024-2029
4.2.3 By Type - Global Anticoagulation Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anticoagulation Therapy Market Size, 2022 & 2029
5.1.2 Hospital Associated Clinics
5.1.3 Independent Clinics
5.1.4 Pharmacy-Based Clinics
5.2 By Application - Global Anticoagulation Therapy Revenue & Forecasts
5.2.1 By Application - Global Anticoagulation Therapy Revenue, 2018-2023
5.2.2 By Application - Global Anticoagulation Therapy Revenue, 2024-2029
5.2.3 By Application - Global Anticoagulation Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anticoagulation Therapy Market Size, 2022 & 2029
6.2 By Region - Global Anticoagulation Therapy Revenue & Forecasts
6.2.1 By Region - Global Anticoagulation Therapy Revenue, 2018-2023
6.2.2 By Region - Global Anticoagulation Therapy Revenue, 2024-2029
6.2.3 By Region - Global Anticoagulation Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anticoagulation Therapy Revenue, 2018-2029
6.3.2 US Anticoagulation Therapy Market Size, 2018-2029
6.3.3 Canada Anticoagulation Therapy Market Size, 2018-2029
6.3.4 Mexico Anticoagulation Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anticoagulation Therapy Revenue, 2018-2029
6.4.2 Germany Anticoagulation Therapy Market Size, 2018-2029
6.4.3 France Anticoagulation Therapy Market Size, 2018-2029
6.4.4 U.K. Anticoagulation Therapy Market Size, 2018-2029
6.4.5 Italy Anticoagulation Therapy Market Size, 2018-2029
6.4.6 Russia Anticoagulation Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Anticoagulation Therapy Market Size, 2018-2029
6.4.8 Benelux Anticoagulation Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anticoagulation Therapy Revenue, 2018-2029
6.5.2 China Anticoagulation Therapy Market Size, 2018-2029
6.5.3 Japan Anticoagulation Therapy Market Size, 2018-2029
6.5.4 South Korea Anticoagulation Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Anticoagulation Therapy Market Size, 2018-2029
6.5.6 India Anticoagulation Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anticoagulation Therapy Revenue, 2018-2029
6.6.2 Brazil Anticoagulation Therapy Market Size, 2018-2029
6.6.3 Argentina Anticoagulation Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anticoagulation Therapy Revenue, 2018-2029
6.7.2 Turkey Anticoagulation Therapy Market Size, 2018-2029
6.7.3 Israel Anticoagulation Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Anticoagulation Therapy Market Size, 2018-2029
6.7.5 UAE Anticoagulation Therapy Market Size, 2018-2029
7 Anticoagulation Therapy Companies Profiles
7.1 CH Boehringer Sohn
7.1.1 CH Boehringer Sohn Company Summary
7.1.2 CH Boehringer Sohn Business Overview
7.1.3 CH Boehringer Sohn Anticoagulation Therapy Major Product Offerings
7.1.4 CH Boehringer Sohn Anticoagulation Therapy Revenue in Global Market (2018-2023)
7.1.5 CH Boehringer Sohn Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Anticoagulation Therapy Major Product Offerings
7.2.4 Bristol-Myers Squibb Anticoagulation Therapy Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Johnson?Johnson
7.3.1 Johnson?Johnson Company Summary
7.3.2 Johnson?Johnson Business Overview
7.3.3 Johnson?Johnson Anticoagulation Therapy Major Product Offerings
7.3.4 Johnson?Johnson Anticoagulation Therapy Revenue in Global Market (2018-2023)
7.3.5 Johnson?Johnson Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Anticoagulation Therapy Major Product Offerings
7.4.4 Pfizer Anticoagulation Therapy Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Anticoagulation Therapy Major Product Offerings
7.5.4 Daiichi Sankyo Anticoagulation Therapy Revenue in Global Market (2018-2023)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 Portola Pharmaceuticals
7.6.1 Portola Pharmaceuticals Company Summary
7.6.2 Portola Pharmaceuticals Business Overview
7.6.3 Portola Pharmaceuticals Anticoagulation Therapy Major Product Offerings
7.6.4 Portola Pharmaceuticals Anticoagulation Therapy Revenue in Global Market (2018-2023)
7.6.5 Portola Pharmaceuticals Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Anticoagulation Therapy Major Product Offerings
7.7.4 Roche Anticoagulation Therapy Revenue in Global Market (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Abbott
7.8.1 Abbott Company Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Anticoagulation Therapy Major Product Offerings
7.8.4 Abbott Anticoagulation Therapy Revenue in Global Market (2018-2023)
7.8.5 Abbott Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anticoagulation Therapy Market Opportunities & Trends in Global Market
Table 2. Anticoagulation Therapy Market Drivers in Global Market
Table 3. Anticoagulation Therapy Market Restraints in Global Market
Table 4. Key Players of Anticoagulation Therapy in Global Market
Table 5. Top Anticoagulation Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anticoagulation Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anticoagulation Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anticoagulation Therapy Product Type
Table 9. List of Global Tier 1 Anticoagulation Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anticoagulation Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anticoagulation Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anticoagulation Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anticoagulation Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anticoagulation Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anticoagulation Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anticoagulation Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anticoagulation Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anticoagulation Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anticoagulation Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anticoagulation Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anticoagulation Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anticoagulation Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anticoagulation Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anticoagulation Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anticoagulation Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anticoagulation Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anticoagulation Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anticoagulation Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anticoagulation Therapy Revenue, (US$, Mn), 2024-2029
Table 30. CH Boehringer Sohn Company Summary
Table 31. CH Boehringer Sohn Anticoagulation Therapy Product Offerings
Table 32. CH Boehringer Sohn Anticoagulation Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. CH Boehringer Sohn Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Summary
Table 35. Bristol-Myers Squibb Anticoagulation Therapy Product Offerings
Table 36. Bristol-Myers Squibb Anticoagulation Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Key News & Latest Developments
Table 38. Johnson?Johnson Company Summary
Table 39. Johnson?Johnson Anticoagulation Therapy Product Offerings
Table 40. Johnson?Johnson Anticoagulation Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson?Johnson Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Anticoagulation Therapy Product Offerings
Table 44. Pfizer Anticoagulation Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Daiichi Sankyo Company Summary
Table 47. Daiichi Sankyo Anticoagulation Therapy Product Offerings
Table 48. Daiichi Sankyo Anticoagulation Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Daiichi Sankyo Key News & Latest Developments
Table 50. Portola Pharmaceuticals Company Summary
Table 51. Portola Pharmaceuticals Anticoagulation Therapy Product Offerings
Table 52. Portola Pharmaceuticals Anticoagulation Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Portola Pharmaceuticals Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Anticoagulation Therapy Product Offerings
Table 56. Roche Anticoagulation Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Abbott Company Summary
Table 59. Abbott Anticoagulation Therapy Product Offerings
Table 60. Abbott Anticoagulation Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Abbott Key News & Latest Developments
List of Figures
Figure 1. Anticoagulation Therapy Segment by Type in 2022
Figure 2. Anticoagulation Therapy Segment by Application in 2022
Figure 3. Global Anticoagulation Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anticoagulation Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anticoagulation Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anticoagulation Therapy Revenue in 2022
Figure 8. By Type - Global Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anticoagulation Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anticoagulation Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 16. US Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 28. China Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anticoagulation Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anticoagulation Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. CH Boehringer Sohn Anticoagulation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb Anticoagulation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson?Johnson Anticoagulation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Anticoagulation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Daiichi Sankyo Anticoagulation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Portola Pharmaceuticals Anticoagulation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Roche Anticoagulation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Abbott Anticoagulation Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
